Form D · Other Technology
BioMetrix Co.
Durham, NC · CIK 0001681909
Offering snapshot reported Apr 5, 2018 · SEC filing
- Reported sold
- $3.01M Offering amount: $4.27M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2018 | Initial | $3,010,001 | No comparison | 26 | SEC filing |
| Aug 29, 2016 | Initial | $350,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-309481
Source: Form D, filed Apr 5, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ivonna N. Dumanyan | Director, Executive |
| Gabrielle M. Levac | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
201 W. Main Street
Durham, NC, 27701
Durham, NC, 27701